Pain

Pain
  • Evaluation
    • General—a subjective experience involving physical, emotional, and cognitive dimensions
    • Mechanism
      • Nociceptive pain—receptors triggered by tissue injury
        • Visceral pain (internal organ pain)
          • Pain in hollow organs is poorly localized, crampy, and/or colicky.
          • Pain in solid organs is poorly localized, achy, and/or dull.
        • Somatic pain—more easily localized, achy, dull, and/or throbbing
      • Neuropathic pain—due to pathologic effects on the central or peripheral nervous system
        • Described as a radiating electric sensation; can also be sharp and burning.
        • Associated with paresthesias, dysesthesias, hyperalgesia, or allodynia.
    • Classification
      • Acute—typically follows an injury, but can be de novo; usually improves as tissue heals.
      • Chronic—pain lasting 3 to 6 months or pain which lasts 1 month longer than expected.
    • Assessment
      • Scales
        • Numeric rating scale (1-10).
        • Visual analogue scale (image to image).
      • Frequent reevaluation is key
  • Management
    • Pain management as outlined by the World Health Organization (WHO) Analgesic Ladder (Table 2.44.1)
  • Treatment—aim for the lowest possible effective dose to minimize side effects.
    • Non-Nonsteroidal anti-inflammatory drugs (NSAID) analgesics
      • Acetaminophen (Tylenol) 325 to 650 mg PO q4h
        • Maximum dose is 1 g per dose; no more than 4 g per 24 hours.
        • For those with liver disease, decrease dose as there is a danger for liver toxicity.
      • Side effects
        • Gastrointestinal (GI) ulceration/bleeding
          • Therefore, consider coadministration with a proton pump inhibitor (PPI).
        • Potential nephrotoxicity in those with renal disease as well as in the elderly
      • Medications
        • Aspirin 325 to 650 mg PO/PR q4h
        • Ibuprofen (Motrin, Advil) 200 to 800 mg PO q6h
        • Naproxen (Naprosyn, Aleve) 250 to 500 mg PO q8h
        • Piroxicam (Feldene) 20 mg PO daily
        • Diclofenac (Voltaren, Cataflam) 50 mg PO q8h
    • Cyclooxygenase-2 (COX-2) specific inhibitors
      • Celecoxib (Celebrex) 200 mg PO BID
        • May have less GI effects than NSAIDS, but be careful with increased cardiovascular risk.
    • Weak opioids and opioid-like medications
      • Propoxyphene HCl (Darvon) 65 mg PO q4h = propoxyphene napsylate 100 mg PO q4h
        • Be careful with continued use as active metabolites accumulate over time.
      • Tramadol (Ultram) 50 to 100 mg PO q6h.
        • May trigger seizures; therefore, avoid in such patients.
    • Strong opioids
Aug 28, 2016 | Posted by in PSYCHIATRY | Comments Off on Pain

Full access? Get Clinical Tree

Get Clinical Tree app for offline access